|
Federal
Register Notices > Manufacturers
2009 > Cerilliant Corporation
FR Doc E9-23067[Federal Register: September 25, 2009 (Volume 74, Number
185)] [Notices] [Page 49020-49021] From the Federal Register Online via GPO
Access [wais.access.gpo.gov] [DOCID:fr25se09-126]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec.
1301.33(a) of Title 21 of the Code of Federal Regulations
(CFR), this is notice that on July 16, 2009, Cerilliant Corporation, 811
Paloma Drive, Suite A, Round Rock, Texas 78665-2402, made application by
renewal to the Drug Enforcement Administration (DEA) as a bulk manufacturer of
the basic classes of controlled substances listed in schedules I and II:
| Drug |
Schedule |
| Cathinone (1235) |
I |
| Methcathinone (1237) |
I |
| N-Ethylamphetamine (1475) |
I |
| N,N-Dimethylamphetamine (1480) |
I |
| Aminorex (1585) |
I |
| 4-Methylaminorex (cis isomer) (1590) |
I |
| Gamma-Hydroxybutyric acid (2010) |
I |
| Methaqualone (2565) |
I |
| Alpha-ethyltryptamine (7249) |
I |
| Lysergic acid diethylamide (7315) |
I |
| 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348) |
I |
| Marihuana (7360) |
I |
| Tetrahydrocannabinols (7370) |
I |
| Mescaline (7381) |
I |
| 3,4,5-Trimethoxyamphetamine (7390) |
I |
| 4-Bromo-2,5-dimethoxyamphetamine (7391) |
I |
| 4-Bromo-2,5-dimethoxyphenethylamine (7392) |
I |
| 4-Methyl-2,5-dimethoxyamphetamine (7395) |
I |
| 2,5-Dimethoxyamphetamine (7396) |
I |
| 2,5-Dimethoxy-4-ethylamphetamine (7399) |
I |
| 3,4-Methylenedioxyamphetamine (7400) |
I |
| 5-Methoxy-3,4-methylenedioxyamphetamine (7401) |
I |
| N-Hydroxy-3,4-methylendioxyamphetamine (7402) |
I |
| 3,4-Methylendioxy-N-ethylamphetamine (7404) |
I |
| 3,4-Methylenedioxymethamphetamine (7405) |
I |
| 4-Methoxyamphetamine (7411) |
I |
| Alpha-methyltryptamine (7432) |
I |
| Bufotenine (7433) |
I |
| Diethyltryptamine (7434) |
I |
| Dimethyltryptamine (7435) |
I |
| Psilocybin (7437) |
I |
| Psilocyn (7438) |
I |
| 5-Methoxy-N,N-diisopropyltyptamine (7439) |
I |
| N-Benzylpiperazine (7493) |
I |
| Acetyldihydrocodeine (9051) |
I |
| Benzylmorphine (9052) |
I |
| Codeine-N-oxide (9053) |
I |
| Dihydromorphine (9145) |
I |
| Heroin (9200) |
I |
| Hydromorphinol (9301) |
I |
| Methyldihydromorphine (9304) |
I |
| Morphine-N-oxide (9307) |
I |
| Normorphine (9313) |
I |
| Pholcodine (9314) |
I |
| Acetylmethadol (9601) |
I |
| Allylprodine (9602) |
I |
| Alphacetylmethadol except levo-alphacetylmethadol (9603) |
I |
| Alphameprodine (9604) |
I |
| Alphamethadol (9605) |
I |
| Betacetylmethadol (9607) |
I |
| Betameprodine (9608) |
I |
| Betamethadol (9609) |
I |
| Betaprodine (9611) |
I |
| Hydroxypethidine (9627) |
I |
| Noracymethadol (9633) |
I |
| Norlevorphanol (9634) |
I |
| Normethadone (9635) |
I |
| Trimeperidine (9646) |
I |
| Phenomorphan (9647) |
I |
| 1-Methyl-4-phenyl-4-propionoxypiperidine (9661) |
I |
| Para-Fluorofentanyl (9812) |
I |
| 3-Methylfentanyl (9813) |
I |
| Alpha-Methylfentanyl (9814) |
I |
| Acetyl-alpha-methylfentanyl (9815) |
I |
| Beta-hydroxyfentanyl (9830) |
I |
| Beta-hydroxy-3-methylfentanyl (9831) |
I |
| Alpha-Methylthiofentanyl (9832) |
I |
| 3-Methylthiofentanyl (9833) |
I |
| Thiofentanyl (9835) |
I |
| Amphetamine (1100) |
II |
| Methamphetamine (1105) |
II |
| Lisdexamfetamine (1205) |
II |
| Phenmetrazine (1631) |
II |
| Methylphenidate (1724) |
II |
| Amobarbital (2125) |
II |
| Pentobarbital (2270) |
II |
| Secobarbital (2315) |
II |
| Glutethimide (2550) |
II |
| Nabilone (7379) |
II |
| 1-Phenylcyclohexylamine (7460) |
II |
| Phencyclidine (7471) |
II |
| 1-Piperidinocyclohexanecarbonitrile (8603) |
II |
| Alphaprodine (9010) |
II |
| Cocaine (9041) |
II |
| Codeine (9050) |
II |
| Dihydrocodeine (9120) |
II |
| Oxycodone (9143) |
II |
| Hydromorphone (9150) |
II |
| Diphenoxylate (9170) |
II |
| Benzoylecgonine (9180) |
II |
| Ethylmorphine (9190) |
II |
| Hydrocodone (9193) |
II |
| Levomethorphan (9210) |
II |
| Levorphanol (9220) |
II |
| Isomethadone (9226) |
II |
| Meperidine (9230) |
II |
| Meperidine intermediate-A (9232) |
II |
| Meperidine intermediate-B (9233) |
II |
| Meperidine intermediate-C (9234) |
II |
| Methadone (9250) |
II |
| Methadone intermediate (9254) |
II |
| Dextropropoxyphene, bulk (non-dosage forms) (9273) |
II |
| Morphine (9300) |
II |
| Thebaine (9333) |
II |
| Levo-alphacetylmethadol (9648) |
II |
| Oxymorphone (9652) |
II |
| Noroxymorphone (9668) |
II |
| Racemethorphan (9732) |
II |
| Alfentanil (9737) |
II |
| Sufentanil (9740) |
II |
| Tapentadol (9780) |
II |
| Fentanyl (9801) |
II |
The company plans to manufacture small quantities of the listed controlled
substances to make reference standards which will be distributed to their
customers.
Any other such applicant, and any person who is presently registered with
DEA to manufacture such substances, may file comments or objections to the
issuance of the proposed registration pursuant to 21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of Diversion
Control, Federal Register Representative (ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be filed no later than November 24,
2009.
Dated: September 17, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E9-23067 Filed 9-24-09; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|
